Par Pharmaceutical Reports Fourth Quarter and Full Year 2008 Results
...cts. Products which experienced significant volume and pricing declines included fluticasone, propranolol, cabergoline, various amoxicillin products, ranitidine syrup, tramadol HCl and acetaminophen tablets driven by Par's exit from the market, and lower royalty payments of ondansetron tablets, among others. ...Fact Sheet: Department of Justice Efforts to Combat Health Care Fraud and Abuse
...greed to pay the United States, 23 states, and the District of Columbia $36.7 million to resolve allegations that it substituted capsules of ranitidine (generic Zantac) for tablets solely to significantly increase the cost and profit rather than for any legitimate medical reason. -- Medt...Par Pharmaceutical Reports First Quarter 2008 Results
... following products: fluticasone, propranolol, various amoxicillin products, tramadol HCl and acetaminophen tablets, glyburide/metformin, cabergoline, ranitidine syrup, as well as lower royalties. Partially offsetting these decreases were increased sales of metoprolol resulting from the launch of additional str...Common Medications Could Cause Physical Impairment in the Elderly
...." Common anticholinergic medicines cited in the study included the blood pressure medication nifedipine (Adalat or Procardia), the stomach antacid ranitidine (Zantac) and the incontinence medication tolterodine (Detrol). The findings, which involved more than 3,000 people, average age 78, were scheduled ...Commonly used medications associated with impaired physical function in older adults
...MS participants include the blood pressure medication nifedipine (Adalat or Procardia), which has mild anticholinergic properties, the stomach antacid ranitidine (Zantac), which has moderate anticholinergic properties, and the incontinence medication tolterodine (Detrol), which is highly anticholinergic. In ...Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
... levels from baseline at the 3 gram CRD5 dosing level. Of note, several patients were identified to have taken proton pump inhibitors (PPI), such as ranitidine and lansoprazole, which inhibit the secretion of gastric acid and reduce the acidity of the stomach. Patients that took PPI regularly during the trial...Par Pharmaceutical Reports Second Quarter 2008 Results
... the three month period decreased 36.4% to $92.9 million compared with the same period in 2007 due to competitive pressure, including for fluticasone, ranitidine HCl syrup, cabergoline, and a decline in many of the Company's other products due to pricing pressures as well as lower royalties driven from ondanset...